Ryan Scott

Leading oncology experts share emerging research and developments shaping the year ahead, from precision medicine to innovative cancer therapies.

Dr. Suneel Kamath sat down for Pancreatic Cancer Awareness Month to discuss advances in treatment and the importance of raising awareness for this disease.

For some with GIST, bezuclastinib plus Sutent led to longer progression-free survival and higher response rates compared with Sutent alone.

In recognition of Pancreatic Cancer Awareness Month, Dr. Suneel Kamath sat down for an interview where he shared his insights on this aggressive disease.

This guide provides an overview of stage 2 uterine (endometrial) cancer, including diagnosis, treatment options, and common side effects. A cancer diagnosis is life-changing, and it is natural to feel

October brought developments in the management of blood cancers, from early-stage multiple myeloma to new cellular therapies and novel drug designations.

In the ASCENT-07 trial, Trodelvy after endocrine therapy did not improve progression-free survival vs chemotherapy in HR+/HER2- metastatic breast cancer.

October brought updates in the lung cancer field, ranging from notable trial results to patient perspectives on navigating treatment and survivorship.

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape genitourinary cancer care.

This year’s Breast Cancer Awareness Month highlighted FDA approvals, survivorship challenges and advances in breast reconstruction.

This is an essential guide on stage 2 cervical cancer to support patients in discussing diagnosis, treatment, and care decisions with their oncology team.

In October 2025, the FDA granted approval to multiple new cancer therapies and supportive care options, covering treatments across the oncologic landscape.

Participating in the SUNRiSE-1 trial taught Bill the value of education, teamwork, and persistence for patients with bladder cancer.

An expert discusses why up to 60% of new trial sites close in year one and what this means for patient access and research supply.

Dr. Vinayak Venkataraman recently sat down with CURE to discuss the evolving treatment landscape for gastrointestinal stromal tumors.

The U.S. FDA has granted orphan drug designation to DPTX3186, an investigational therapy being developed for gastric cancer treatment.

Bill joined the SUNRiSE-1 trial for Inlexzo, avoiding bladder removal, staying active and reaching full remission from BCG-unresponsive bladder cancer.

Dr. Francesca Palandri discusses anemia in myelofibrosis, its impact on survival and quality of life, and the potential of Ojjaara for patients.

Stage 2 lymphoma is treatable. Diagnosis and treatment depend on subtype, but most patients achieve excellent outcomes with modern therapies.

Learn what stage 2 ovarian cancer means, how it’s diagnosed, treatment options like surgery and chemotherapy, and key questions to ask your oncologist.

Adding Xtandi to androgen deprivation therapy and radiation did not significantly improve metastasis-free survival in high-risk localized prostate cancer.

Ponsegromab improved body weight, suppressed GDF-15 and was well-tolerated over 64 weeks in cancer-associated cachexia, including patients switching from placebo.

The FDA granted orphan drug designation to the investigational therapy MNV-201 for myelodysplastic syndrome, a serious, age-related blood disorder.

Brittney Nichols discussed the emotional and physical side effects of lung cancer treatment, as well as feelings of isolation in newly diagnosed patients.

Patients with advanced renal cell carcinoma whose disease has progressed on first-line therapies may benefit from the combination of Fruzaqla and Tyvyt.

Patients living with myelofibrosis who also experience anemia may see meaningful improvements in blood counts when treated with Vonjo.

While Breast Cancer Awareness Month raises funds and awareness, for survivors, it can painfully remind them of all they’ve endured.

Brittney Nichols highlights the need for early detection and stresses that lung cancer is not only caused by smoking; anyone can develop the disease.

Dr. Ravi Munver discusses how minimally invasive techniques allow patients to preserve kidney function and practical guidance for navigating treatment.

This guide provides a supportive overview of stage 2 melanoma, covering diagnosis, treatment options, and key questions for your medical team.